Novo Nordisk A/S (NVO)
After hours:
Chart Events
Performance Outlook
| Previous Close | 95.44 |
| Open | 94.19 |
| Bid | 94.66 x 900 |
| Ask | 95.18 x 900 |
| Day's Range | 93.99 - 95.87 |
| 52 Week Range | 66.59 - 117.35 |
| Volume | |
| Avg. Volume | 1,281,261 |
| Market Cap | 218.444B |
| Beta (5Y Monthly) | 0.26 |
| PE Ratio (TTM) | 31.26 |
| EPS (TTM) | 3.04 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.47 (1.54%) |
| Ex-Dividend Date | Aug 16, 2021 |
| 1y Target Est | 115.85 |
Fair Value
Related Research
- Novo Nordisk A/SAnalyst Report: Novo Nordisk A/SWith almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.RatingFair ValueEconomic Moat19 days agoMorningstar
- GuruFocus.com
Private Ocean, LLC Buys Regal Rexnord Corp, T-Mobile US Inc, Vanguard Total Bond Market ETF, ...
San Rafael, CA, based Investment company Private Ocean, LLC (Current Portfolio) buys Regal Rexnord Corp, T-Mobile US Inc, Vanguard Total Bond Market ETF, WisdomTree U.S.
- GuruFocus.com
DDD Partners, LLC Buys Intel Corp, Novo Nordisk A/S, Broadcom Inc, Sells Adaptive ...
Investment company DDD Partners, LLC (Current Portfolio) buys Intel Corp, Novo Nordisk A/S, Broadcom Inc, DocuSign Inc, Atlas Corp, sells Adaptive Biotechnologies Corp, Editas Medicine Inc, Magna International Inc, Activision Blizzard Inc, Gentex Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, DDD Partners, LLC.
- GlobeNewswire
Novo Nordisk A/S – Share repurchase programme
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 24 January 2022 – On 5 November 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period
